Jie Du, Ph.D.
President & CEO

Dr. Jie Du is a seasoned pharmaceutical executive and entrepreneur. She is one of the founders at Frontage Laboratories, which started its operations in 2001. Frontage has since grown into a multi national contract research organization (CRO), serving pharmaceutical clients in North America and Asia. After exiting her holdings at Frontage, she has been active as an angel investor of life science start-ups.  In 2009, Dr. Du founded JDP Therapeutics. She is leading JDP in becoming a significant player in pharmaceutical innovation and development.  

Dr. Du’s pharmaceutical experience extends 20 years at Abbott, Merck and URL Pharma. During her tenure of increasing responsibilities at these companies, she led activities in pharmaceutical product development, project management, legal/patent strategies, product portfolio management, clinical development, and regulatory areas.  Dr. Du is a brilliant initiator on pharmaceutical strategies. Three of her patents (assigned to URL Pharma) were licensed to King/Pfizer. Prior to starting JDP Therapeutics, Dr. Du served as the Director of Scientific Affairs at URL Pharma, a specialty pharma company in Philadelphia.  Mainly in charge of clinical studies, she was one of the key corporate members responsible for the company’s outstanding growth from ~$50 M annual sales to ~$600 M.

Dr. Du’s endless creativity has made her a renowned inventor of many U.S. and international patents.  Dr. Du earned her Ph.D. degree from School of Pharmacy at University of the Pacific in California.

John M. Morrash
Chief Financial Officer

Mr. Morrash is a Senior Financial Executive with over 32 years of diversified financial experience.  His last ten years have been the Chief Financial Officer and Sr. Vice President of Superior Group, Inc., West Conshohocken, PA.  Mr. Morrash has extensive experience in fund raising, financial analysis, planning, acquisitions, international finance, divestitures, product and plant rationalizations, and etc.  Mr. Morrash completed over 25 M&A and divesture transactions.

Mr. Morrash’s international experience includes active involvement in international business operations and M&A transactions in Ireland, England, Mexico, Canada, Belgium, Germany, Italy, Spain, Denmark and Brazil.  Over the course of his career he has worked with manufacturing and distribution companies, including: prescription pharmaceutical, medical/surgical, aerospace, power generation, oil and gas, automotive, material handling, and other durable goods.

Mr. Morrash received his CPA certificate in the state of Pennsylvania in 1978.

Sharon Clarke
Chief Business Officer

Sharon Clarke is an accomplished pharmaceutical industry executive with more than 20 years of direct senior leadership experience in sales, marketing, training, strategic development, business acquisitions and commercial operations.  As the President and General Manager of Meda Pharmaceuticals (the leading division of Meda AB, a "Top 50” global specialty pharmaceutical company), Sharon’s deep knowledge of the allergy/respiratory, pain, CNS, ophthalmology and oncology palliative care markets resulted in successful launches of more than 5 products that together generated more than $175 million in revenues.  Ms. Clarke built and led MedPointe Pharmaceutical’s Allergy Specialty Team and directed the Sales Force to exceed revenue forecasts in this specialty arena.

As the President of Patriot Advisors, a business consulting firm, and Vice President of Global Initiatives in The Xtra Mile Group, Sharon counseled emerging biotechnology companies and established global pharmaceutical companies seeking to optimize organizational effectiveness and manage change.    

Sharon has been recognized as a Healthcare Businesswomen’s Association (HBA) Rising Star and is a former Trustee of the Healthcare Institution of New Jersey (HINJ).  She was graduated magna cum laude from East Tennessee State University with degrees in Microbiology and Chemistry.  She is a member of the University Board of Trustees.